Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

NCT07721467 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

NIH

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Psilocybin
OTHER: Cognitive Training

Sponsor

National Institute on Aging (NIA)